Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.
Cardinal Health (NYSE: CAH), a leader in pharmaceutical distribution and healthcare supply chain solutions, maintains this dedicated news hub for investors and industry stakeholders. Our continuously updated repository provides official press releases, regulatory filings, and market-moving developments.
This resource delivers critical updates across CAH's core operations including pharmaceutical network expansions, medical-surgical product innovations, and strategic healthcare partnerships. Users gain access to essential documents such as quarterly earnings reports, SEC filings, and leadership announcements.
Key coverage areas include operational milestones in specialty drug distribution, advancements in clinical supply chain technology, and regulatory updates affecting global healthcare logistics. The curated format enables efficient tracking of CAH's market position within the competitive medical distribution sector.
Bookmark this page for direct access to primary-source Cardinal Health communications, ensuring informed decision-making through verified company disclosures. Combine regular monitoring with SEC.gov filings for comprehensive investment research.
Cardinal Health reported third quarter fiscal year 2024 revenues of $54.9 billion, a 9% increase from the previous year. GAAP operating earnings were $367 million, with GAAP diluted EPS at $1.05. Non-GAAP operating earnings increased 10% to $666 million, and non-GAAP diluted EPS rose 20% to $2.08. The company raised its fiscal year 2024 non-GAAP EPS guidance to $7.30 to $7.40 and provided preliminary guidance for fiscal year 2025 of at least $7.50.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
